Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of primary prevention strategy guided by SCORE2 versus coronary artery calcium scoring in a non-diabetic population.

European journal of internal medicine·2026
Same author

Ticagrelor promotes arterial healing and shows superiority to clopidogrel in preventing neoatherosclerosis.

Blood vessels, thrombosis & hemostasis·2025
Same author

Long-Term Outcomes of Conservative Versus Invasive Approach of Coronary Aneurysm.

Reviews in cardiovascular medicine·2024
Same author

Association between Dental and Cardiovascular Diseases: A Systematic Review.

Reviews in cardiovascular medicine·2024
Same author

Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years.

Open heart·2024
Same author

Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial.

Circulation. Cardiovascular interventions·2024

Related Experiment Videos

[Coronary syndromes in the elderly].

Jean-Paul Bounhoure1, Didier Carrié, Jacques Puel

  • 1Service de cardiologie, CHU Toulouse-Rangueil, 2, avenue J. Poulhes, Toulouse 31403.

Bulletin De L'Academie Nationale De Medecine
|January 2, 2007
PubMed
Summary

Acute coronary syndromes (ACS) in the elderly present poor prognoses due to comorbidities and late diagnosis. Optimal management strategies, including reperfusion therapies, require further dedicated trials for this population.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Geriatric Medicine

Background:

  • Acute coronary syndromes (ACS) are prevalent in elderly individuals, associated with significant morbidity and mortality.
  • Older patients often have severe coronary artery disease and comorbidities, complicating treatment decisions and leading to reluctance in adopting advanced revascularization techniques.
  • Elderly patients are frequently underrepresented in clinical trials, limiting evidence-based treatment guidelines.

Purpose of the Study:

  • To review the current understanding of acute coronary syndrome (ACS) management in the elderly.
  • To highlight the challenges and therapeutic options for ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE-ACS) in older adults.
  • To emphasize the need for further research and dedicated clinical trials.

Main Methods:

  • Review of existing literature on ACS in the elderly.
  • Analysis of treatment strategies including intravenous thrombolysis, primary angioplasty, and interventional approaches for NSTE-ACS.
  • Discussion of risk factors, outcomes, and therapeutic outcomes in the geriatric population.

Main Results:

  • Intravenous thrombolysis reduces mortality by 26% but increases hemorrhage risk in the elderly.
  • Primary angioplasty in high-volume centers shows promise for STEMI, reducing mortality and recurrent ischemia.
  • Interventional strategies for NSTE-ACS, including dual antiplatelet therapy and glycoprotein IIb/IIIa inhibitors, demonstrate superior reduction in major adverse clinical events compared to conservative management.

Conclusions:

  • ACS management in the elderly is complex, requiring careful consideration of individual risk profiles.
  • While reperfusion therapies offer benefits, their application in older adults necessitates a nuanced approach due to increased risks.
  • Dedicated randomized trials are crucial to optimize ACS treatment strategies and improve outcomes in the elderly population.